Photo from Ajay Major/LinkedIn
Aug 15, 2023, 19:20
Ajay Major: Our multicenter study of checkpoint inhibitor outcomes in the post-CAR-T setting is now published online in full at Blood Advances.
As Ajay Major stated on LinkedIn:
“Our multicenter study of checkpoint inhibitor outcomes in the post-CAR-T setting is now published online in full at Blood Advances. Response rates and survival are poor with these agents and novel approaches (such as bispecifics) are needed. Many thanks to my mentor Dr. Kline and all of our collaborators for bringing this manuscript to fruition.”
For the article click here
Source: Ajay Major / LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19